Soranobu Ninomiya

Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs

Soranobu Ninomiya, Neeharika Narala, Leslie E. Huye et al. · Blood · 2015 · 314 citations · Full text

Life Sciences, Immunology, Oncology +11

Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma

Nobuhiko Nakamura, Takeshi Hara, Yuhei Shibata et al. · Annals of Hematology · 2015 · 101 citations

Medicine, Immunology, Oncology +13

Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP

Soranobu Ninomiya, Takeshi Hara, Hisashi Tsurumi et al. · Annals of Hematology · 2010 · 86 citations

Medicine, Hematology, Oncology +13

Possible Role of Visfatin in Hepatoma Progression and the Effects of Branched-Chain Amino Acids on Visfatin-Induced Proliferation in Human Hepatoma Cells

Soranobu Ninomiya, Masahito Shimizu, Kenji Imai et al. · Cancer Prevention Research · 2011 · 57 citations

Medicine, Biochemistry, Oncology +17

Low Levels of Serum Tryptophan Underlie Skeletal Muscle Atrophy

Soranobu Ninomiya, Nobuhiko Nakamura, Hiroshi Nakamura et al. · Nutrients · 2020 · 55 citations · Full text

Life Sciences, Biochemistry, Oncology +17